1832 Asset Management L.P. - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.

Quarter-by-quarter ownership
1832 Asset Management L.P. ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q1 2018$4,000
-33.3%
2700.0%0.00%
Q4 2017$6,000
+50.0%
2700.0%0.00%
Q3 2017$4,000
-100.0%
270
-100.0%
0.00%
-100.0%
Q2 2017$9,545,000
+57.3%
550,9440.0%0.04%
+95.5%
Q1 2017$6,068,000
-77.8%
550,944
-59.7%
0.02%
-52.2%
Q4 2016$27,345,000
+39.4%
1,366,945
+70.7%
0.05%
-37.8%
Q3 2016$19,611,000
+21.6%
800,7890.0%0.07%
+17.5%
Q2 2016$16,123,000
-57.3%
800,789
-3.4%
0.06%
-31.5%
Q1 2016$37,716,000
-78.5%
829,236
-51.5%
0.09%
-87.8%
Q4 2015$175,085,000
-47.5%
1,708,672
-8.5%
0.76%
-45.8%
Q3 2015$333,666,000
-30.4%
1,867,832
-13.6%
1.40%
-14.2%
Q2 2015$479,672,000
+12.1%
2,162,329
+0.0%
1.63%
+1.1%
Q1 2015$427,850,000
-10.2%
2,162,013
-35.0%
1.61%
+9.0%
Q4 2014$476,554,000
-2.8%
3,328,612
-11.0%
1.48%
-7.7%
Q3 2014$490,057,000
+22.8%
3,738,456
+18.4%
1.60%
+27.2%
Q2 2014$399,075,000
+68.7%
3,156,925
+70.6%
1.26%
+54.6%
Q1 2014$236,566,000
+27.0%
1,850,036
+16.6%
0.81%
+13.5%
Q4 2013$186,210,000
+41.9%
1,586,303
+26.0%
0.72%
+23.0%
Q3 2013$131,234,000
-11.5%
1,259,233
-26.8%
0.58%
-10.5%
Q2 2013$148,329,0001,720,9430.65%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2015
NameSharesValueWeighting ↓
Brave Warrior Advisors 6,050,442$763,082,00030.78%
LeVasseur Capital Partners LLC 190,404$24,014,00029.50%
FARLEY CAPITAL L.P. 333,081$42,008,00027.09%
Ruane, Cunniff & Goldfarb 34,298,384$4,325,712,00023.07%
ValueAct Holdings 18,923,877$2,386,679,00017.64%
Tesuji Partners 1,368,040$172,537,00017.22%
Brahman Capital Corp. 3,902,877$492,231,00013.63%
Arrow Capital Management, LLC 197,500$24,909,00013.60%
Hound Partners 2,851,175$359,590,00013.45%
Ratan Capital Management LP 731,960$92,315,00013.09%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders